TERUMO TAZUNA BALLOON ETC SIZES
TERUMO REJUIN ETC SIZES
TERUMO ACCUFORCE ETC SIZES
TERUMO ELIMINATE ASSPIRATION CATH 6FGC EG1602
Related products
-
PTCA Balloon Ryurei
Description
Confidence in your hands
Ryurei™ has superior crossability1 thanks to the combination of low distal profiles and Terumo’s hydrophilic M coating. The short balloon bonding and reinforced shaft1 results in enhanced trackability1 while maintaining excellent pushability1.
These features can increase physician’s confidence in success even during complex procedures.
CharacteristicsExcellent Pusability
The combination of flexible distal part, tapered core wire on the midshaft and the thick proximal hypotube, results in smooth and balanced transition across the entire catheter for high transmission force, resulting in excellent pushability
Superior Crossability2
Thanks to the combination of distal low profiles and the Terumo hydrophilic M-Coat, Ryurei offers low friction in crossing tight lesions
Enhanced Trackability2
With an optimal tip design and improved balloon bonding, Ryurei provides enhanced trackability, even in tortuous anatomy and difficult to navigate vessels.
General specifications
Shaft diameter 1.9 Fr/0.64 mm Proximal • 2.5 Fr/0.84 mm Middle • 2.4 Fr/0.79 mm to 2.7 Fr/0.89 mm (tapered) Distal (1.00 to 1.50 mm) • 2.6 Fr/0.87 mm Distal (2.00 to 4.00 mm) Usable length 145 cm Balloon markers # 1(Ø1.0 to Ø 1.5 mm) • 2(Ø2.0 to Ø4.0 mm) Nominal pressure 6 atm / 608 kPa Rated burst pressure Ø1.0 – 3.0 mm=14 atm(1419kPa) • Ø3.25 – 4.0 mm = 12 atm(1216 kPa) Guidewire compatibility Maximum diameter: 0.014″ / 0.36 mm Lesion entry profile 0.41 mm (Ø1.00 to Ø1.50 mm) • 0.43 mm (Ø2.00 to Ø4.00 mm) Coating Hydrophilic Item specifications
Balloon length / Product code
Balloon Diameter 5 mm 10 mm 15 mm 20 mm 30 mm 40 mm 1.00 mm DC-RR1005HH 1.25 mm DC-RR1205HH DC-RR1210HH DC-RR1215HH DC-RR1220HH 1.50 mm DC-RR1505HH DC-RR1510HH DC-RR1515HH DC-RR1520HH 2.00 mm DC-RR2010HHW DC-RR2015HHW DC-RR2020HHW DC-RR2030HHW DC-RR2040HHW 2.25 mm DC-RR2210HHW DC-RR2215HHW DC-RR2220HHW 2.50 mm DC-RR2510HHW DC-RR2515HHW DC-RR2520HHW DC-RR2530HHW DC-RR2540HHW 2.75 mm DCRR2710HHW DC-RR2715HHW DC-RR2720HHW 3.00 mm DC-RR3010HHW DC-RR3015HHW DC-RR3020HHW DC-RR3030HHW DC-RR3040HHW 3.25 mm DC-RR3210HHW DC-RR3215HHW DC-RR3220HHW 3.50 mm DC-RR3510HHW DC-RR3515HHW DC-RR3520HHW DC-RR3530HHW DC-RR3540HHW 3.75 mm DC-RR3710HHW DC-RR3715HHW DC-RR3720HHW 4.00 mm DC-RR4010HHW DC-RR4015HHW DC-RR4020HHW References
1 Ryurei φ1.00-5mm compared to Tazuna 1.25-10 mm- Data on file ISCD-416-31-4
* For Ryurei Ø 1.00 mm – Ø 1.50 mm.
** For Ryurei Ø 1.00mm – 5mm 2 Compared to Tazuna PTCA dilatation catheter
-
OCTOPUS TISSUE STABILIZER
Octopus
Tissue Stabilizers
OCTOPUS TISSUE STABILIZERS
Our newest generation tissue stabilizer features automatic pod spread for effective visualization.
SUMMARY
OCTOPUS EVOLUTION AS – THE NEXT GENERATION TISSUE STABILIZER
The newest generation tissue stabiliser from Medtronic demonstrates an enduring commitment to the cardiac surgeon. With all the same features of the Octopus™ Evolution – enhanced stability, flexibility, and a lower profile for unlimited positioning options – the Octopus Evolution AS offers an automatic pod spread feature that enhances visibility at the anastomotic site.
- Automatic pod spread for effective visualisation of the anastomotic site
- Very secure arm for maximum stabilization
- Greater flexibility enables unlimited positioning options
- Simple, secure, one-handed attachment of clamp to the retractor
OCTOPUS EVOLUTION – LOW PROFILE WITH FLEXIBILITY AND REACH
The Octopus Evolution stabilizer provides enhanced stability, flexibility, and a lower profile for unlimited positioning options.
Enhanced stability and flexibility features:
- Improved visualisation with:
- Lower profile headlink
- Surgeon controlled pod-spread
- Allowance for multiple device positions including pods-up, pods-down and pods-to-the-side applications
- Increased flexibility and range of motion
- Longer, effective reach of the articulating arm provides easier access to all vessels
- Simple, secure, one-handed engagement of clamp and turret assembly
THE OCTOPUS 4.3 STABILISER FEATURES SUPERIOR ARM STRENGTH AND UNMATCHED STABILITY IN THE CLAMP/TURRET MECHANISM.
- Dual vacuum tubes offer superior tissue capture
- Internal cable enables arm twisting for maximum access and flexibility
- Reinforced arm links offer better stabilisation
- Whale tail tightens easily
- Swivel turret offers access while maximising visualisation
- Head lock design allows “toes up” position, pod spread and bend
- Rigid clamp designed to eliminate rocking
OCTOPUS 4 – EXCELLENT STABILITY AND FLEXIBILITY
The Octopus 4 tissue stabiliser includes innovative features, such as clear, malleable pods combined with a smaller diameter, more flexible arm, and an ultra-low headlink profile.
- Pod spreading optimises sewing space and stability of anastomotic site
- Reduced headlink profile improves visibility of surgical site
- Rigid, multi-material arm reduces movement at the anastomotic site
- Smaller diameter, more flexible arm offers greater flexibility in positioning
- Smaller, color-coded whale tail provides minimal obstruction
- Single vacuum tubing line minimises obstruction
- Innovative turret design increases effective arm reach, dramatically increasing positioning options with 360-degree movement
-
RADIFOCUS REDIAL SHEATH
Providing you the best range of Terumo Radifocus Radial Introducer Sheath and Cordis Femoral Introducer Sheath with effective & timely delivery.
The radial artery access sheath is used to gain arterial access and facilitate the insertion of catheters or other equipment for diagnostic and vascular interventions.
- The Cordis AVANTI®+ Introducer is the pioneer of catheter sheath introducer technology. Featuring a patented SLIX Valve, the AVANTI®+ introducer provides smooth transitions, monitoring capabilities and exceptional performance for your procedural success, as well as
- A hexacuspid design that provides a balance between catheter maneuverability and hemostasis.
- A rotating suture collar that facilitates procedural flexibility. It stays in place and allows patient movement.
- A kink-resistant cannula design integrating a soft, flexible inner layer with a stiffer outer layer designed to increase bendability and support, and decrease kinking.
- Atraumatic tip transitions for both the sheath and the vessel dilator are uniquely tapered and manicured. This results in smooth insertions and helps to minimize damage upon entry.
As part of the circulatory system, the radial artery supplies blood from the heart to the forearm.
Radial sheaths had the smallest OD (1 Fr smaller) when compared to similar sized conventional sheaths. For instance, the OD of 4 Fr radial sheath (1.610 ± 0.006 mm) is essentially the same as the OD of the conventional 3 Fr (1.644 ± 0.016 mm) and 3.3 Fr (1.635 ± 0.005 mm) sheaths.
-
CLOSUREFAST
ClosureFast™
procedureMinimally invasive thermal
treatment for vein disease
and varicose veins.
The ClosureFast procedure uses radiofrequency energy or heat to close the diseased vein, which redirects blood flow to healthy veins, relieving symptoms.Before the procedure
You will have an ultrasound imaging exam of the leg being treated. This exam is important for assessing the diseased superficial vein and planning the procedure.
During the procedure
Your doctor will discuss the procedure with you. Here is a brief summary of what to expect:
- The ClosureFast procedure is performed on an outpatient basis. Your doctor will perform the ClosureFast procedure. Using an ultrasound, your doctor will position a catheter in the diseased vein through a small opening in the skin.
- The small catheter delivers heat to the vein wall, causing it to shrink and seal the vein. Once the diseased vein is closed, blood will reroute itself to other healthy veins.
After the procedure
- You will be taken to the recovery area to rest.
- Following the procedure, your doctor will apply a simple bandage over the insertion site and will give you compression stockings to aid in the healing process. Your doctor may encourage you to walk and to refrain from extended standing and strenuous activities for a period of time. The average patient typically resumes normal activities within a few days.1,2
- Your doctor will recommend follow-up care as needed.
-
Benefits of the ClosureFast procedure
- Relief of symptoms after two days, with a noticeable improvement in one to two week
- Minimally invasive outpatient procedure
- Less pain and bruising than laser treatment
- Faster recovery than laser treatment
- Proven results with positive patient experience
- Rapid recovery — on average, patients resume normal activities within a few days
- Lasting results — the only radiofrequency energy procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at five years.4
Adverse events can include nerve injury, hematoma, phlebitis, thrombosis, and/or pulmonary embolism.
Type of therapy
Thermal shrinkage of the vein wall with radiofrequency energy or heatInpatient or outpatient procedure
Outpatient procedureOne- versus two-leg treatment
Typically, each leg will be treated in separate appointmentsNeedle sticks required
One needle stick for vein access. Typically, 5 to 10 needle sticks for anesthesia.Typical post-treatment recovery
Healing of vein access site, anesthetic needle stick sites, and also healing of ablated vein sectionCompression hose
Required for approximately one weekProcedure success rate
91.9% after five years4ClosureFast procedure FAQ
Is the ClosureFast procedure painful?
Most patients report feeling little, if any, pain during the ClosureFast procedure.3 Your doctor will give you a local or regional anesthetic to numb the treatment area.
When can I return to normal activity?
Patients treated with the ClosureFast procedure may resume normal activity more quickly than patients who undergo surgical vein stripping or laser ablation. With the ClosureFast procedure, the average patient typically resumes normal activity within a few days.2 For a few weeks following the treatment, your vein specialist may recommend a regular walking regimen and suggest you refrain from strenuous activities (heavy lifting, for example) or prolonged periods of standing.
When will my symptoms improve?
Most patients report relief of symptoms after two days, with a noticeable improvement in one to two weeks.
Is there any scarring, bruising, or swelling after the procedure?
Most patients report limited to no scarring, bruising, or swelling following the ClosureFast procedure.3
How is the ClosureFast procedure different from endovenous lasers?
Both Closure Fast and lasers use thermal technology to deliver heat into the diseased vein, but they each use a different method of delivery. Despite their similarity in using heat, a 2009 study showed that the ClosureFast procedure is associated with lower rates of pain, bruising, and complications and a faster improvement in patients’ quality of life when compared to 980 nm laser ablation.4
How is the Closure Fast procedure different from vein stripping?
During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull the vein out of the leg. With the ClosureFast procedure, only one small incision is made at the insertion site and the vein is then treated and left in place. ClosureFast is a minimally invasive approach that reduces the likelihood of pain and bruising, associated with vein stripping surgery.1
Is the ClosureFast procedure covered by insurance?
Many patients have access to the ClosureFast procedure through their insurance coverage plan. Insurance companies detail access to the ClosureFast procedure and other radiofrequency ablation procedures in coverage policies for varicose veins or chronic venous insufficiency. As with all healthcare procedures, you may also have some cost associated with receiving treatment, such as a copay or coinsurance. Please reach out to your insurance company to discuss your specific plan coverage and potential costs prior to seeking treatment
Reviews
There are no reviews yet.